Owners' perspective on using a continuous glucose monitoring system with their diabetic pet.

FreeStyle Libre® CGM is highly accepted by pet owners and may improve diabetic management in cats and dogs.

This retrospective survey study evaluated owner perspectives on the FreeStyle Libre® continuous glucose monitoring (CGM) system in 35 diabetic pet owners (18 cat, 17 dog owners) from an initial cohort of 65, yielding a 53% response rate. The study assessed usability, owner satisfaction, and perceived impact on pet quality of life and diabetes mellitus control. Key findings demonstrated high owner acceptance, with 91% willing to reuse the sensor and 94% recommending it to other owners. From the owners' perspective, 77% reported enhanced diabetes control and 57% noted improved pet quality of life compared to the time of diagnosis. The sensor demonstrated reasonable durability, remaining attached for 11–14 days in 63% of cases, though spontaneous detachment occurred in 28% of patients and active removal by the pet occurred in one case. Owner-reported stress levels during sensor use were moderate (mean 4.57/10), while cost perception was moderately high (mean 7.37/10). Despite cost concerns, overall satisfaction was high (median 8/10). Approximately 31% of owners frequently expressed concern regarding glucose readings, suggesting a need for ongoing owner education. The CGM system offers a minimally invasive, user-friendly alternative to traditional blood glucose monitoring methods such as portable glucometers or glucose curves, with potential benefits for both glycemic management and quality of life for diabetic pets and their owners. Limitations include the small sample size, retrospective design, and reliance on subjective owner-reported outcomes.

This summary was distilled by AI and may occasionally misinterpret data. Confirm critical details with the primary literature before clinical application.